| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |